Used in organic synthesis as a building block for pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing for the formation of carbon-carbon bonds in drug discovery. The presence of both amine and fluorine substituents offers sites for further functionalization and can enhance binding selectivity and metabolic stability in medicinal chemistry applications. Commonly employed in the synthesis of potential treatments for cancer, inflammation, and neurological disorders.